CHI Announces Starting an NGS Lab Part 1: Technical Considerations Short Course

NEEDHAM, Mass. - Nov. 19, 2013 - PRLog -- Cambridge Healthtech Institute announces its Starting an NGS Lab Part 1: Technical Considerations short course, which will take place at the Moscone North Convention Center in San Francisco, CA on February 9, 2014 from 2:00-5:00 PM.  This course is co-organized with the Association for Molecular Pathology.

Chairperson:

• Madhuri Hegde, Ph.D., FACMG. Associate Professor of Human Genetics, Executive Director, Emory Genetics Lab (2013-2014 AMP Genetics Subdivision Chair)

Agenda at a Glance:

• Evolution of NGS Labs and Choosing the Right Instruments
Madhuri Hegde, Ph.D., FACMG. Associate Professor of Human Genetics, Executive Director, Emory Genetics Lab (2013-2014 AMP Genetics Subdivision Chair)

• Quality Control/Quality Assurance and Validation/Compliance
Monica J. Basehore, Ph.D., FACMG, Director, Molecular Diagnostic Laboratory, Greenwood Genetic Center (AMP Member)

• Incorporating Bioinformatic Tools and Pipelines in Medical NGS
Birgit H. Funke, Ph.D., FACMG, Assistant Professor of Pathology, MGH/Harvard Medical School, Director of Clinical Research and Development, Laboratory for Molecular Medicine (AMP Member)

To view a detailed agenda for this course and to register, visit http://bit.ly/I33gpV

About Cambridge Healthtech Institute (http://www.healthtech.com)

CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI's Media Group, which includes news websites and e-newsletters including Bio-IT World and Clinical Informatics News.

About Molecular Med Tri-Conference (http://www.triconference.com)

The 21st International Molecular Medicine Tri-Conference is the industry's Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 15 main programs. For the first time in over 10 years we're bringing back a dedicated conference on sequencing. As many will recall this event's infancy was heavily devoted to the Human Genome Project and we are excited to reintroduce sequencing to this event.